US6268392B1
(en)
*
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US20110196039A9
(en)
*
|
1994-10-05 |
2011-08-11 |
Kaesemeyer Wayne H |
Controlled release arginine formulations
|
US6235706B1
(en)
|
1996-09-18 |
2001-05-22 |
Merck & Co., Inc. |
Combination therapy for reducing the risks associated with cardiovascular disease
|
SI20109A
(sl)
*
|
1998-12-16 |
2000-06-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Stabilna farmacevtska formulacija
|
US7608640B2
(en)
*
|
1999-03-02 |
2009-10-27 |
Jallal Messadek |
Glycine betaine and its use
|
US6569461B1
(en)
|
1999-03-08 |
2003-05-27 |
Merck & Co., Inc. |
Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
|
CN1092986C
(zh)
*
|
1999-08-16 |
2002-10-23 |
上海本草生物医学工程研究所 |
一种用于降血脂的辅酶a口服制剂及制备方法和应用
|
US6696086B1
(en)
*
|
1999-09-10 |
2004-02-24 |
Lek Pharmaceuticals D.D. |
Solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, and its preparation
|
US20020028240A1
(en)
*
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
PL355844A1
(en)
*
|
2000-08-09 |
2004-05-31 |
Panacea Biotec Limited |
Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation
|
CN1240377C
(zh)
*
|
2001-03-27 |
2006-02-08 |
兰贝克赛实验室有限公司 |
普伐他汀的稳定的药物组合物
|
US20080199522A1
(en)
*
|
2001-04-12 |
2008-08-21 |
Astellas Pharma, Inc. |
Timed-release compression-coated solid composition for oral administration
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
WO2003000239A1
(en)
*
|
2001-06-21 |
2003-01-03 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions containing pravastatin
|
US6669955B2
(en)
*
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
US6576256B2
(en)
|
2001-08-28 |
2003-06-10 |
The Brigham And Women's Hospital, Inc. |
Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
AR036354A1
(es)
*
|
2001-08-31 |
2004-09-01 |
Takeda Chemical Industries Ltd |
Preparacion solida
|
AU2002353659A1
(en)
*
|
2001-12-18 |
2003-07-15 |
Synthon B.V. |
Simvastatin dosage forms
|
ES2298351T5
(es)
*
|
2002-01-16 |
2012-01-26 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Método para producir un comprimido farmacéutico de dos capas que comprenden telmisartán e hidroclorotiazida.
|
BE1015608A6
(fr)
*
|
2003-07-15 |
2005-06-07 |
Messadek Jallal |
Traitement des arterites.
|
MY131170A
(en)
*
|
2002-03-28 |
2007-07-31 |
Nissan Chemical Ind Ltd |
Therapeutic agent for glomerular disease
|
CA2483099A1
(en)
*
|
2002-05-03 |
2003-11-13 |
Hexal Ag |
Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
|
US7232828B2
(en)
*
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
US20070172453A1
(en)
*
|
2002-08-30 |
2007-07-26 |
Vincent Geenen |
Tolerogenic approach for type 1 diabetes
|
US8980870B2
(en)
|
2002-09-24 |
2015-03-17 |
Boehringer Ingelheim International Gmbh |
Solid telmisartan pharmaceutical formulations
|
JP4494712B2
(ja)
*
|
2002-11-12 |
2010-06-30 |
大日本住友製薬株式会社 |
マルチプルユニット型徐放性製剤
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
JP2006515294A
(ja)
*
|
2002-12-12 |
2006-05-25 |
アクティブバイオティクス インコーポレイティッド |
アテローム性動脈硬化症およびその関連疾患を治療または予防するための方法および試薬
|
ES2300628T3
(es)
*
|
2002-12-20 |
2008-06-16 |
Pfizer Products Inc. |
Formas de dosificacion que comprenden un inhibidor de cetp y un inhibidor de la hmg-coa reductasa.
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
EP1615632B1
(fr)
*
|
2003-04-17 |
2006-12-06 |
Jallal Messadek |
Formulations orales flottantes pour la liberation controlee de la betaine
|
US20040241234A1
(en)
*
|
2003-06-02 |
2004-12-02 |
Alpharma, Inc. |
Controlled release press-coated formulations of water-soluble active agents
|
BR8302502U
(pt)
*
|
2003-06-10 |
2005-04-19 |
Medley S A Ind Farmaceutica |
Embalagem, ou kit de medicamentos, ou apresentação facilitadora da administração de medicamentos por parte de indivìduos em prevenção e/ou tratamento da doença aterosclerótica
|
ATE482698T1
(de)
*
|
2003-06-18 |
2010-10-15 |
Inst Cardiologie De Montreal M |
Vermeidung von vorhofflimmern (af) mit der verwendung von statin
|
AR045062A1
(es)
*
|
2003-07-18 |
2005-10-12 |
Santarus Inc |
Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050031700A1
(en)
*
|
2003-07-18 |
2005-02-10 |
Sanatarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
US7041286B2
(en)
*
|
2003-07-23 |
2006-05-09 |
Nerenberg Arnold P |
Composition for mitigating a pernicious thrombotic event
|
CN1822820A
(zh)
*
|
2003-07-28 |
2006-08-23 |
雷迪实验室有限公司 |
心血管疾病的治疗和预防
|
US20060128657A1
(en)
*
|
2003-08-04 |
2006-06-15 |
Jallal Messadek |
Selected betaines and their uses
|
DE602004012763T2
(de)
*
|
2003-10-10 |
2009-05-07 |
Solvay Pharmaceuticals Gmbh |
Pharmazeutische zusammensetzung mit einem selektiven i1 imidazolin-rezeptor-agonisten und einem angiotensin-ii-rezeptorblocker
|
US20050113452A1
(en)
*
|
2003-10-20 |
2005-05-26 |
Moshe Flashner-Barak |
Composition and dosage form for sustained effect of levodopa
|
US7670624B2
(en)
*
|
2004-01-29 |
2010-03-02 |
Astella Pharma Inc. |
Gastrointestinal-specific multiple drug release system
|
EP1718303A4
(en)
*
|
2004-02-10 |
2010-09-01 |
Santarus Inc |
COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
|
US8535716B2
(en)
*
|
2004-04-01 |
2013-09-17 |
Tsrl, Inc. |
Methods and composition of extended delivery of water insoluble drugs
|
US20050239845A1
(en)
*
|
2004-04-16 |
2005-10-27 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2571447A1
(en)
*
|
2004-06-28 |
2006-01-05 |
Howard J Smith & Associates Pty Ltd |
Composition and method for treatment and prevention of atherosclerosis
|
BE1016128A6
(fr)
*
|
2004-07-22 |
2006-03-07 |
Messadek Jallal |
Combinaisons therapeutiques
|
US20060020031A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Roger Berlin |
Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
|
US20060025486A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Roger Berlin |
Compositions containing policosanol and B vitamins and their pharmaceutical uses
|
US20060034913A1
(en)
*
|
2004-08-13 |
2006-02-16 |
James Gaede |
Multiplex drug delivery device
|
US20060039890A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Renshaw Perry F |
Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
|
DE102004042139B4
(de)
*
|
2004-08-31 |
2009-06-10 |
Aristocon Verwaltungs- Gmbh |
Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
|
US20060069042A1
(en)
*
|
2004-09-24 |
2006-03-30 |
Hu Oliver Y |
Cytochrome P450 2C9 inhibitors
|
US8758814B2
(en)
|
2004-10-08 |
2014-06-24 |
Mcneil-Ppc, Inc. |
Chewable enteric coated aspirin tablets
|
US8057820B2
(en)
*
|
2004-10-08 |
2011-11-15 |
Mcneil-Ppc, Inc. |
Enteric coated aspirin granules comingled with binder
|
ES2255426B1
(es)
*
|
2004-10-19 |
2007-08-16 |
Gp Pharm, S.A. |
Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
|
WO2006050581A2
(en)
*
|
2004-11-10 |
2006-05-18 |
Jallal Messadek |
Betaine as agent against arthropod - or mosquito -borne diseases
|
KR100646576B1
(ko)
|
2005-02-15 |
2006-11-23 |
한국유나이티드제약 주식회사 |
고지혈증 환자의 동맥경화증 예방을 위한 에이치엠지이-씨오에이 환원효소 저해제 및 장용코팅된 아스피린을 함유하는 복합 펠렛
|
WO2006086856A1
(en)
|
2005-02-15 |
2006-08-24 |
Messadek, Jallal |
Combination therapeutic compositions and method of use
|
KR100648825B1
(ko)
|
2005-02-22 |
2006-11-24 |
한국유나이티드제약 주식회사 |
당뇨병 환자의 동맥경화증 예방을 위한 혈당강하제, 에이치엠지이-씨오에이 환원효소 저해제 및 장용코팅된 아스피린을 함유하는 복합 펠렛
|
AU2006229688B2
(en)
|
2005-02-24 |
2012-07-26 |
Diffusion Pharmaceuticals Llc |
Trans carotenoids, their synthesis, formulation and uses
|
WO2006099244A1
(en)
*
|
2005-03-11 |
2006-09-21 |
Hong Kong Nitric Oxide Limited |
Combination therapy for endothelial dysfunction, angina and diabetes
|
MX2007013486A
(es)
*
|
2005-04-27 |
2008-03-14 |
Jallal Messadek |
Combinaciones de insulinas.
|
EP1741427A1
(en)
*
|
2005-07-06 |
2007-01-10 |
KRKA, D.D., Novo Mesto |
Pharmaceutical composition comprising simvastatin and ezetimibe
|
WO2007011886A2
(en)
*
|
2005-07-18 |
2007-01-25 |
Reliant Pharmaceuticals, Inc. |
Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof
|
BRPI0616223A2
(pt)
*
|
2005-09-15 |
2011-06-14 |
Otsuka Pharma Co Ltd |
combinaÇço de fÁrmacos
|
US8440695B2
(en)
*
|
2005-11-09 |
2013-05-14 |
St Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
US20070116756A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Dr. Reddy's Laboratories Limited |
Stable pharmaceutical compositions
|
WO2007103557A2
(en)
*
|
2006-03-09 |
2007-09-13 |
Reliant Pharmaceuticals, Inc. |
Coating capsules with active pharmaceutical ingredients
|
US8784886B2
(en)
*
|
2006-03-09 |
2014-07-22 |
GlaxoSmithKline, LLC |
Coating capsules with active pharmaceutical ingredients
|
US20070254897A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Resolvyx Pharmaceuticals, Inc. |
Compositions and methods for the treatment of cardiovascular disease
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
BRPI0602179A
(pt)
*
|
2006-06-08 |
2008-01-22 |
Biolab Sanus Farmaceutica Ltda |
composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
|
EP2051583A4
(en)
*
|
2006-08-16 |
2011-09-14 |
Aspreva Pharmaceuticals Ltd |
COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE AND INFLAMMATORY DISEASES
|
US9744137B2
(en)
*
|
2006-08-31 |
2017-08-29 |
Supernus Pharmaceuticals, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US8298576B2
(en)
|
2006-11-17 |
2012-10-30 |
Supernus Pharmaceuticals, Inc. |
Sustained-release formulations of topiramate
|
US20090042849A1
(en)
*
|
2006-12-06 |
2009-02-12 |
Yochai Birnbaum |
Phosphorylation of 5-lipoxygenase at ser523 and uses thereof
|
KR100870396B1
(ko)
*
|
2006-12-07 |
2008-11-25 |
보령제약 주식회사 |
심혈관계 질환 치료용 경구투여제제
|
US9095519B2
(en)
*
|
2007-02-09 |
2015-08-04 |
Alphapharm Pty Ltd |
Dosage form containing two or more active pharmaceutical ingredients in different physical forms
|
KR100955669B1
(ko)
*
|
2007-08-13 |
2010-05-06 |
한올바이오파마주식회사 |
HMGCoA 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법
|
PL2200588T3
(pl)
*
|
2007-09-25 |
2019-09-30 |
Solubest Ltd. |
Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
|
EA023338B1
(ru)
*
|
2007-10-17 |
2016-05-31 |
Тодд Ф. Овокайтис |
Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
|
TWI435726B
(zh)
*
|
2007-10-17 |
2014-05-01 |
Todd F Ovokaitys |
室溫下穩定之非晶形阿斯匹靈及其製備方法
|
WO2009065193A1
(en)
*
|
2007-11-21 |
2009-05-28 |
Jallal Messadek |
Treatment of aspirin resistance with betaine and/or betaine enriched molasses
|
US20090226515A1
(en)
*
|
2008-03-04 |
2009-09-10 |
Pharma Pass Ii Llc |
Statin compositions
|
US8753680B2
(en)
*
|
2008-03-28 |
2014-06-17 |
Ferrer Internacional S.A. |
Capsule for the prevention of cardiovascular diseases
|
TWI516501B
(zh)
*
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Pcsk9拮抗劑類
|
BRPI0924198A2
(pt)
*
|
2009-01-22 |
2016-02-16 |
Sanofi Sa |
combinação de ingredientes ativos contendo um fármaco anti-inflamtório não esteroidal e um derivado de colchicosida
|
CN101491508B
(zh)
*
|
2009-01-23 |
2011-04-20 |
上海微丸医药开发有限公司 |
一种阿司匹林肠溶微丸胶囊的制备方法
|
US20110196383A1
(en)
*
|
2009-05-05 |
2011-08-11 |
Atherolysis Medical, Inc |
Atherosclerotic Plaque Dissolution Composition
|
CN101897710A
(zh)
*
|
2009-05-27 |
2010-12-01 |
北京奥萨医药研究中心有限公司 |
含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸的药物组合物及其用途
|
AU2010263245A1
(en)
|
2009-06-22 |
2012-01-19 |
Diffusion Pharmaceuticals Llc |
Diffusion enhancing compounds and their use alone or with thrombolytics
|
EA021588B1
(ru)
|
2009-06-25 |
2015-07-30 |
Тетра Сиа |
Бетаиновые соли ацетилсалициловой кислоты
|
KR101193493B1
(ko)
*
|
2010-02-02 |
2012-10-22 |
한미사이언스 주식회사 |
소수성 첨가제가 함유된 분리막으로 코팅된 아스피린 및 HMG?CoA 환원효소 억제제를 포함하는 복합제제
|
US9535075B2
(en)
|
2010-03-25 |
2017-01-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein and gene biomarkers for rejection of organ transplants
|
CA2801292C
(en)
|
2010-06-02 |
2019-01-22 |
Diffusion Pharmaceuticals Llc |
Oral formulations of bipolar trans carotenoids
|
TR201005325A2
(tr)
|
2010-06-30 |
2012-01-23 |
Bi̇lgi̇ç Mahmut |
Atorvastatin ve aspirin içeren farmasötik formülasyonlar
|
KR20120068277A
(ko)
*
|
2010-12-17 |
2012-06-27 |
한미사이언스 주식회사 |
HMG-CoA 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제
|
US20130345182A1
(en)
*
|
2010-12-21 |
2013-12-26 |
Silanes Laboratories |
Stable composition comprising cholesterol-lowering agents, antihypertensive agents and antiplatlet agents
|
KR101298788B1
(ko)
*
|
2011-03-15 |
2013-08-22 |
보령제약 주식회사 |
안정성이 개선된 복합제제
|
AR086675A1
(es)
*
|
2011-06-14 |
2014-01-15 |
Merck Sharp & Dohme |
Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa-4 con simvastatina
|
UY34478A
(es)
|
2011-11-30 |
2013-06-28 |
Takeda Pharmaceutical |
Comprimido recubierto seco
|
WO2013112933A1
(en)
*
|
2012-01-27 |
2013-08-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Identification of new therapeutic uses for known therapeutic agents
|
WO2013133620A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Yuhan Corporation |
Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
|
WO2013152230A1
(en)
*
|
2012-04-04 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
US20140274991A1
(en)
|
2013-03-15 |
2014-09-18 |
Cubist Pharmaceuticals, Inc. |
Ceftolozane pharmaceutical compositions
|
US9872906B2
(en)
|
2013-03-15 |
2018-01-23 |
Merck Sharp & Dohme Corp. |
Ceftolozane antibiotic compositions
|
EP2810644A1
(en)
|
2013-06-06 |
2014-12-10 |
Ferrer Internacional, S.A. |
Oral formulation for the treatment of cardiovascular diseases
|
LV14963B
(lv)
|
2013-06-28 |
2015-10-20 |
Tetra, Sia |
Endoteliālās disfunkcijas korektors
|
US20150072005A1
(en)
*
|
2013-09-10 |
2015-03-12 |
Vitalis Llc |
Aspirin formulation for increased efficacy
|
US10202598B2
(en)
|
2014-05-30 |
2019-02-12 |
Todd Frank Ovokaitys |
Methods and systems for generation, use, and delivery of activated stem cells
|
WO2015185240A1
(en)
|
2014-06-04 |
2015-12-10 |
Sigma-Tau Industrire Farmaceutiche Riunite S.P.A. |
Compositions containing simvastatin in omega-3 polyunsaturated fatty acids
|
WO2015187974A1
(en)
|
2014-06-06 |
2015-12-10 |
Ovokaitys Todd Frank |
Methods and compositions for increasing the bioactivity of nutrients
|
US10384985B2
(en)
|
2014-06-06 |
2019-08-20 |
B.K. Consultants, Inc. |
Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
|
BE1023011B1
(nl)
*
|
2015-08-05 |
2016-11-04 |
Nordic Specialty Pharma Bvba |
Acetylsalicylzuur tablet met onmiddellijke afgifte
|
FR3040303B1
(fr)
*
|
2015-08-27 |
2019-04-05 |
Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger |
Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
|
JP7032320B2
(ja)
|
2016-03-24 |
2022-03-08 |
ディフュージョン・ファーマシューティカルズ・エルエルシー |
癌を処置するための、化学療法及び放射線療法を伴う二極性トランスカロテノイドの使用
|
FR3060390B1
(fr)
*
|
2016-12-19 |
2020-09-25 |
Bh Pharma |
Formulation comprenant de la pravastatine et de l'acide acetylsalycilique
|
US20200129440A1
(en)
*
|
2017-01-23 |
2020-04-30 |
Dong Wha Pharm. Co., Ltd. |
Complex formulation comprising hmg-coa reductase inhibitor and clopidogrel
|
US11185530B2
(en)
*
|
2017-03-09 |
2021-11-30 |
Ajou University Industry-Academic Cooperation Foundation |
Composition for preventing or treating hearing loss, containing atorvastatin as active ingredient
|